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Abstract
Background: The classic neuritic b-amyloid plaque of Alzheimer’s disease (AD) is typically associated with activated
microglia and neuroinflammation. Similarly, cerebrovascular b-amyloid (Ab) deposits are surrounded by perivascular
macrophages. Both observations indicate a contribution of the mononuclear phagocyte system to the development of
b-amyloid.
Methods: Human CD14-positive mononuclear phagocytes were isolated from EDTA-anticoagulated blood by
magnetic activated cell sorting. After a cultivation period of 72 hours in serum-free medium we assessed the
protein levels of amyloid precursor protein (APP) as well as the patterns and the amounts of released Ab peptides
by ELISA or one-dimensional and two-dimensional urea-based SDS-PAGE followed by western immunoblotting.
Results: We observed strong and significant increases in Ab peptide release upon phagocytosis of acetylated low
density lipoprotein (acLDL) or polystyrene beads and also after activation of the CD14/TLR4 pathway by stimulation
with LPS. The proportion of released N-terminally truncated Ab variants was increased after stimulation with
polystyrene beads and acLDL but not after stimulation with LPS. Furthermore, strong shifts in the proportions of
single Ab1-40 and Ab2-40 variants were detected resulting in a stimulus-specific Ab signature. The increased release
of Ab peptides was accompanied by elevated levels of full length APP in the cells. The maturation state of APP
was correlated with the release of N-terminally truncated Ab peptides.
Conclusions: These findings indicate that mononuclear phagocytes potentially contribute to the various
N-truncated Ab variants found in AD b-amyloid plaques, especially under neuroinflammatory conditions.
Background
The neuropathological changes typically found in Alzhei-
mer’s disease (AD) brains include the formation of neuro-
fibrillary tangles, the deposition of multiple Ab peptide
variants into neuritic b-amyloid plaques and neuroinflam-
mation. Neuritic plaques are complex lesions which vary
in their morphology and Ab peptide composition [1].
Classic neuritic plaques consist of a dense b-amyloid core
which is surrounded by elevated numbers of activated
microglial cells and paired helical filament-type dystrophic
neurites [2]. Ab peptides ending at valine-40 (Ab40) are
highly abundant in cored plaques while diffuse Ab plaques
consist mainly of longer peptides ending at alanine-42
(Ab42) [3]. It is assumed that microglia is involved in the
maturation of plaques, especially in the deposition of
Ab40 [4]. Similarly, cerebrovascular b-amyloid deposits
that are also found in AD are surrounded by perivascular
macrophages [5]. Both of these plaque-associated cell
types belong to the mononuclear phagocyte system and
are partly recruited from blood [6]. In addition to Ab1-40
and Ab1-42 several other Ab species, especially N-trun-
cated forms, were detected in neuritic and vascular
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any medium, provided the original work is properly cited.b-amyloid plaques. N-truncated Ab peptides are present in
the earliest stages of AD pathology and their proportion in
b-amyloid deposits increases along the course of the dis-
ease correlating with the Braak stage [7,8]. N-truncated
Ab peptide variants account for more than 60% of all Ab
peptides found in cored plaques at Braak stage VI [8,9].
However, neither their origin nor their role in amyloido-
genesis is fully understood.
It is also not clear whether activated microglia contri-
butes to the formation of neuritic plaques by defective
phagocytosis of Ab or by the de novo production and
subsequent deposition of Ab peptides [10]. De novo pro-
duction and subsequent release of Ab results from the
proteolytic processing of amyloid precursor protein by
b-a n dg-secretases in distinct cellular compartments
[11]. While APP695 is predominantly expressed by neu-
rons, the longer KPI-containing isoforms APP751 and
APP770 are more abundantly expressed by microglia
and blood mononuclear cells [12-14]. APP undergoes
N- and O-glycosylation during maturation in the endo-
plasmic reticulum and the Golgi network [15]. The gly-
cosylation state was shown to influence the transport of
APP to distinct cellular compartments and thereby its
proteolytic processing [15-17].
Several surface receptors were reported to be
involved in phagocytosis and the interaction of micro-
glia/mononuclear phagocytes with fibrillar Ab or b-
amyloid plaques. Scavenger receptors are strongly
expressed in association with senile plaques in AD
[18]. Both class A (SR-A) and class B scavenger recep-
tors (SR-B) are expressed on macrophages and macro-
phage-derived cells and are activated by acetylated low
density lipoprotein (acLDL), oxidized LDL (oxLDL),
advanced glycation endproducts (AGE) and by phago-
cytosis of polystyrene beads [19,20]. They are also the
main receptors mediating the microglial activation by
fibrillar Ab and endocytosis of fibrillar Ab by microglia
[21,22]. Furthermore, the expression of the lipopoly-
saccharide (LPS) receptor (CD14) is increased on corti-
cal and hippocampal microglia in AD and in primary
murine microglial cells fibrillar Ab1-42 is phagocytosed
in a CD14-dependent manner [23].
We have previously investigated the Ab peptides
released by human mononuclear phagocyte cultures as
a model for microglia. We observed that their activa-
tion by adherence to polystyrene surfaces induced an
overall increase of Ab peptide release and a relative
increase in N-terminally truncated Ab species [24].
The objective of the present study was to investigate
the influence of plaque-associated inflammatory events
such as phagocytosis and activation of the LPS recep-
tor on the secretion of Ab peptides by human mono-
nuclear phagocytes.
Methods
Monocyte isolation and culture
EDTA-anticoagulated blood was obtained by venipunc-
ture from young, non demented indi-viduals. Signed con-
sent was obtained from all volunteers and the study
procedures were approved by the ethics committee of the
University of Erlangen-Nuremberg. Peripheral blood
mononuclear cells (PBMC) were isolated by Ficoll centri-
fugation as detailed previously [24]. Afterwards, CD14
positive mononuclear phagocytes were selected by anti-
body mediated removal of non-monocytes by magnetic
activated cell sorting (MACS) according to the manufac-
turers protocol (Monocyte Isolation Kit II, Miltenyi
Biotech, Germany). The purity of the negatively selected
monocyte fraction was ≥90%, while CD61 positive
thrombocytes accounted for only ~3% of total cell counts
as assessed by flow cytometry (data not shown). Cells
were resuspended in serum-free (Ab-free) AIM-V med-
i u m ,a n ds e e d e da tad e n s i t yo f2×1 0
6/ml in 24-well
ultra low binding plates (Corning, The Netherlands).
Mononuclear phagocytes were stimulated with LPS
10 ng/ml (from E. coli serotype O111:B4; Sigma-Aldrich,
Germany), carboxylated polystyrene beads 4*10
7/ml
(1 μm; Polysciences, Germany), or acLDL 10 μg/ml (Invi-
trogen, Germany). After 72 h, the supernatants of 2-6
separate wells were pooled, spun down (750 g, 5 min)
and immediately frozen until further evaluation. In two
independent experiments glycosylation of APP was inhib-
ited by adding tunicamycin or brefeldin A (both from
Sigma-Aldrich, Germany) at a concentration of 10 μg/ml
to unstimulated cultures 6 h, 4 h, 2 h or 0.5 h prior to
cell lysis after 72 h in vitro. Cell viability was assessed
morphologically and by the CytoTox 96® lactate dehydro-
genase assay kit (Promega, Germany). Only viable cell
cultures were used for Ab assessment.
Ab40-ELISA
Abx-40 in culture supernatants was quantified by ELISA
according to the manufacturer’s instructions (WAKO,
Japan). 100 μl of undiluted supernatant were incubated
over night at 4°C on the assay plate precoated with the
mab BNT77 (binding AA11-28 of the Ab peptide).
Serial dilutions of synthetic Ab1-40 in standard diluent
buffer served as reference. Detection was performed
with horseradish peroxidase-conjugated F(ab’) antibody
fragments (BA27) for 2 h at 4°C. The absorption at 450
nm was measured with an Infinite™M200 ELISA reader
and evaluated with Magellan v6.5 software (both
TECAN, Austria).
One and two-dimensional Ab-SDS-PAGE/immunoblot
For the analysis of Ab peptides, the urea version of the
bicine/sulfate SDS-PAGE and semi-dry western blotting
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Briefly, following immunoprecipitation with the mab
1E8 (Bayer-Schering Pharma, Germany), the Ab peptides
were separated on a MiniProtean™II electrophoresis unit
(BioRad, Germany). After blotting onto Immobilon™-P
PVDF membranes (Millipore, Germany), immunodetec-
tion was performed with the mab 1E8. The blots were
finally developed with ECL™Advance chemiluminescent
peroxidase substrate (GE Healthcare, Germany) accord-
ing to the manufacturer’s protocol and analysed with
the Fluor-S Max Multi-Imager and the Quantity
One™v4.1 software (BioRad, Munich, Germany). All
samples were run in duplicates and each gel carried a
dilution series of synthetic Ab peptides. Isoelectric
focusing and second dimension Ab-SDS-PAGE/immu-
noblot (2D-Ab-WIB) was performed as described before
[26]. Briefly, after immunoprecipitation with mab 1E8-
activated magnetic beads (Dynal, Hamburg, Germany)
the Ab peptides were eluted and loaded onto 7 cm IPG
strips (linear pH gradient, pH 4-7). Isoelectric focussing
was performed with the Ettan™ IPGphor™ II System (GE
Healthcare, Munich, Germany). The second dimension
separation of the isoelectrically focussed Ab peptides
was performed as described above using the Hoefer
electrophoresis system. Immunodetection was per-
formed with the mab 1E8 which is specific to human
Ab peptides starting at either aspartate-1 or alanine-2
under the conditions of Ab-WIB (Bayer Schering
Pharma AG, Berlin, Germany) [27]. Synthetic peptides
Ab1-38/40/42 were purchased from Bachem (Weil a.
Rhein, Germany). Ab1-37/39 and Ab2-40/42 were obtained
from Biosyntan (Berlin, Germany).
Western blot analysis of APP
For the analysis of intracellular APP, the cells were
washed in PBS and lysed in RIPA-buffer (50 mM HEPES,
150 mM NaCl, 1%(v/v) Igepal, 0.5%(w/v) Na-DOC, 0.1%
SDS and 1 tablet Complete Mini protease inhibitor cock-
tail (Roche, Germany)) on ice. After centrifugation the
cell lysates were adjusted to equal protein concentrations
and boiled for 5 min with the appropriate amount of
fourfold concentrated sample buffer to yield a final con-
centration of 62.5 mM Tris/HCL pH 6.8, 2%(w/v) SDS,
10%(v/v) Glycerol; 100 mM DTT and 0.005%(w/v) bro-
mophenolblue. Cell lysates were separated on 7.5%T/
2.7%C Tris-Glycin SDS-polyacrylamide gels and blotted
onto Immobilon™-P PVDF membranes (Millipore,
Germany) by semi-dry transfer at a constant current of
1 mA/cm
2 for 60 min with 25 mM Tris, 192 mM glycine,
20%(v/v) methanol [28,29]. The membranes were blocked
with 2% ECL™Advance blocking agent (GE Healthcare,
Germany) in PBS/0.075% Tween-20 (45 min, RT) and
incubated overnight at 4°C with mab 1E8. The next day
the membranes were washed and incubated for 1 h at RT
with a horseradish peroxidase-coupled secondary anti-
body (Calbiochem-Merck, Germany). After washing, the
blots were developed with ECL™-plus chemiluminescent
substrate according to the manufacturer’si n s t r u c t i o n s
and visualized with an Intas Imager (Intas, Göttingen,
Germany). For b-actin staining the membranes were cut
at approximately 60 kDa. The upper piece was stained
for APP as indicated above. The lower piece was stained
with an anti b-actin polyclonal antibody (Abcam,
Cambridge, UK). Semiquantitative analysis of APP was
performed with Quantity One™v4.1 software (BioRad,
Germany).
Statistical analysis
Data are expressed as means ± standard deviation (SD)
of at least 4 separate monocyte cultures from different
donors. Statistical evaluation was performed with Prism
5.0 (GraphPad Software Inc., San Diego, USA) using
Kruskal Wallis test followed by Dunn’s test for multiple
comparison or one-way ANOVA and Dunnett’s multiple
comparison test. For correlation analysis Pearson’sc o r -
relation coefficient was calculated. Differences were con-
sidered significant for p < 0.05.
Results
Inflammatory conditions and phagocytosis increase the
release of Ab peptides by mononuclear phagocytes
Supernatants from mononuclear phagocytes stimulated
with polystyrene beads, acLDL and LPS were subjected
to immunoprecipitation and 1D-Ab-WIB. The release of
total Ab increased approximately 3-4 fold after stimula-
tion with polystyrene beads or acLDL and reached levels
of 18 and 28 pg/ml, respectively (Table 1). The concen-
trations of released Ab1-40 were elevated to a similar
extent. The latter finding was additionally confirmed by
Ab40-ELISA revealing similar elevations of Abx-40
(Fig. 1). Significant increases of Ab secretion were also
induced by LPS (Table 1). The combined stimulation of
mononuclear phagocytes with polystyrene beads and
LPS had an additive effect on the Ab release (Table 1).
Phagocytosis but not LPS increase the proportion
of N-terminally truncated Ab peptides released by
mononuclear phagocytes
To resolve the highly complex pattern of Ab peptides
secreted by mononuclear phago-cytes and to study in
detail the specific effects of each stimulus on different
Ab variants, two-dimensional 2D-Ab-WIB was per-
formed (Fig. 2). It appeared that the increases in total
Ab release after different stimuli were accompanied by
substantial alterations in the relative abundance of the
different Ab variants. In untreated control cells, Ab1-40
accounted for ~64% of total Ab while this relative pro-
portion was significantly lower in cells treated with
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by increased proportions of several Ab peptides with
more alkaline pI values representing N-terminally trun-
cated Ab2-x variants (Table 2). In contrast, the relative
amount of secreted Ab1-42 remained constant under all
tested stimulation paradigms.
Most interestingly, the proportion of N-terminally
truncated Ab2-x peptides increased several-fold upon
phagocytic stimuli. After stimulation with acLDL, Ab2-x
species together represented almost 30% of Abtotal
(Fig. 2D, Table 2). Even higher proportions of more
than 40% of Abtotal were observed after stimulation with
polystyrene beads (Fig. 2E, Table 2). In comparison,
Ab2-x species accounted for only ~12% of Abtotal in con-
trol cultures (Fig. 2B, Table 2). The proportion of
N-truncated Ab species in LPS-stimulated mononuclear
phagocyte cultures was only marginally increased and
the overall Ab pattern resembled that found in unstimu-
lated controls with Ab1-x species accounting for more
than 80% of Abtotal (Fig. 2C, Table 2). The combination
of an inflammatory (LPS) with a phagocytic stimulus
(polystyrene beads) integrates the effect of the two indi-
vidual treatments with a strong release of both, Ab1-x
and Ab2-x species (Fig. 2F).
A stimulus-specific signature of secreted Ab peptides
can be deduced from the distribu-tion of the four Ab40
peptides previously designated as Ab1-40,A b2-40,A b2-40
a,
Ab2-40
b [24]. The identity of the peptides was concluded
on the basis of co-migration with synthetic Ab peptides
and their detection with N- and C- terminally specific
antibodies [24]. The peptides display isoelectric points
of approximately 5.37, 6.37, and 5.45 and their positions
after 2D-Ab-WIB separation as well as a scheme to indi-
cate the terminology used in Table 2 are indicated in
Fig. 2F. The sum of proportions of the four Ab40 pep-
tides remained stable at about 60% of Abtotal indepen-
dently of the stimulus (Table 2, Fig. 3). Nonetheless,
characteristic shifts in the relative proportion of indivi-
dual Ab40 variants were observed. Most obviously a
prominent increase of Ab2-40
a at the expense of Ab1-40
was visible in cultures stimulated with polystyrene
beads.
Inflammatory conditions and phagocytosis increase
protein levels of APP
To examine the effects of LPS and phagocytic stimuli on
the APP metabolism we assessed the protein levels of
APP in mononuclear phagocytes. Electrophoretic separa-
tion of APP holoprotein from unstimulated cells
revealed a pattern of 4 prominent APP-reactive bands
with molecular weights of approximately 120-140 kDa
presumably corresponding to differently maturated
forms of APP751 and APP770 (Fig. 4). Inhibition of O-
glycosylation with brefeldin A resulted in the time-
dependent reduction of the protein level of total APP
and a slight decrease in the apparent molecular weights
of APP bands 1 and 4 (Fig. 4A). In contrast, inhibition
of N-glycosylation with tunicamycin induced a strong
increase in total APP and a strong increase of the lighter
bands APP2/APP3 at the expense of the heaviest band
APP1 (Fig. 4B). Taken together the results indicate that
only APP1 accounts for fully glycosylated, mature APP.
Table 1 Semiquantitative assessment of Ab1-40 and Abtotal by 1D-Ab-WIB
CON
(n = 21)
Polystyrene beads
(n = 15)
acLDL
(n = 10)
LPS
(n = 11)
Polystyrene beads + LPS
(n = 8)
Ab1-40 (pg/ml) 1.8 ± 1.3 4.7 ± 2.1** 10.7 ± 6.5*** 5.9 ± 5.1** 17.2 ± 14.9***
Abtotal (pg/ml)
1 8.5 ± 5.9 17.9 ± 6.6** 28.4 ± 13.8*** 18.1 ± 8.5* 43.8 ± 26.9***
Values are expressed as mean ± SD; *P <. 0 5 ,* * P < .01, ***P < .001 compared with CON (Kruskal-Wallis test followed by Dunn’s multiple comparison test).
1 Abtotal refers to Ab1-38/39/40/42, Ab2-40 and Ab2-40
a.
Figure 1 Release of Abx-40 by mononuclear phagocytes is
induced by phagocytosis of polystyrene beads or acetylated LDL.
Human mononuclear phagocytes were freshly isolated by density
gradient centrifugation followed by depletion of all non phagocytes
with magnetic activated cell sorting. Cells were resuspended in AIM-V
medium and seeded on ultra-low attachment plates. They were left
either untreated (CON) or stimulated with 4*10
7/ml polystyrene beads
(PB) or 10 μg/ml acLDL (acLDL). A bx-40 was assessed in supernatants
after 72 h in vitro with a sandwich ELISA using the mab BNT77
(binding AA11-28 of Ab) as the capturing antibody and horseradish
peroxidase conjugated F(ab’) fragments of the BA27 (specific for the
C-terminus of Ab40) as the detection antibody. Note the 8-11 fold
increased release of Abx-40 after treatment of mononuclear phagocytes
with polystyrene beads or acLDL. (p < 0,01, one-way ANOVA followed
by Dunnett’sm u l t i p l ec o m p a r i s o nt e s t )
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after stimulation with either acLDL, poly-styrene beads,
LPS or LPS together with polystyrene beads (Fig. 5).
Although statistically significant only for the stimulation
with acLDL and LPS, the expression of total APP
increased approximately twofold in all stimulation para-
digms compared to control (Fig. 5A, B).
Phagocytosis but not LPS increases the levels of mature/
glycosylated APP
On the basis of the experiments with brefeldin A and tuni-
camycin, the ratio APP1:APP2+3 was calculated to
monitor the effects of stimulation on the maturation/gly-
cosylation state of APP (Fig. 5C). The ratio APP1:APP2+3
increased significantly upon phagocytosis of polystyrene
beads as compared to control (p < 0.001) and a similar
trend was observed after stimulation with acLDL. These
data indicate an increased protein level of mature APP. In
contrast, the ratio APP1:APP2+3 decreased significantly
upon stimulation with LPS (p < 0.01). In cultures stimu-
lated with LPS together with polystyrene beads the ratio
APP1:APP2+3 remained at the control level.
The proportion of released N-truncated Ab peptides
(sum of Ab variants migrating at pI 6.37) correlated
Figure 2 Release of N-terminally truncated Ab-peptides is induced by polystyrene beads and acetylated LDL but not by LPS.C D 1 4
+
monocytes were negatively isolated by MACS and kept in serum-free AIM-V medium in ultra low binding culture vessels. Following stimulation
for 72 h cell culture supernatants were collected and subjected to immunoprecipitation with mab 1E8-preactivated magnetic beads. Released Ab
peptides were assessed by isoelectric focusing on linear IPG strips (pH4-7) and subsequent Ab-SDS-PAGE (2D-Ab-WIB). (A) shows the separation
of the following synthetic standard Ab peptides: Ab1-37,A b1-38,A b1-39,A b1-40,A b1-42 as well as Ab2-40 and Ab2-42. For a better orientation,
synthetic Ab1-37,A b1-38,A b1-39,A b1-40,A b1-42 were additionally separated one-dimensionally on the right side of each gel. The following figures
show 2D-Ab-WIBs from supernatants of untreated cultures (B) or cultures stimulated with LPS 10 ng/ml (C), acLDL 10 μg/ml (D) and 1 μm
carboxylated polystyrene beads 4*10
7/ml (E) that were processed as described above. In (F), the LPS stimulus was combined with polystyrene
beads at the concentrations used in (C) and (E), respectively. Distinct Ab reactive spots are indicated by characters and by the respective pI
values. Note the proportional increase of released N-truncated Ab peptides migrating at pI 6.37 upon phagocytosis (D, E, F).
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band 1 (Pearson’s r = .705, p = .0105), while the correla-
tion with the immature APP band 2 was negative and
even stronger (Pearson’s r = - .845, p = .0005) (Fig. 6).
These data suggest a relationship between APP glycosy-
lation/maturation and the generation of N-truncated Ab
peptide variants.
Discussion
A direct role of the LPS receptor (CD14/TLR4) in the pha-
gocytosis of fibrillar Ab was suggested because of its upre-
gulation in b-amyloid plaque-associated microglia and its
interaction with fibrillar Ab [23,30]. In the current study,
we observed that both, phagocytosis and activation of
the LPS receptor induced a twofold increase in APP
Table 2 Proportions of single Ab peptide species secreted by non-adherent mononuclear phagocytes stimulated with
polystyrene beads, acLDL or LPS (2D-Ab-WIB, mab 1E8)
CON
(n = 5)
Polystyrene beads
(n = 5)
acLDL
(n = 4)
LPS
(n = 4)
Polystyrene beads + LPS
(n = 4)
Spot pI Ab identity proposed % of total Ab
5.37-A 5.37 Ab1-40 63.9 ± 3.8 30.0 ± 7.0*** 37.5 ± 6.5*** 49.2 ± 9.5* 42.0 ± 12.0**
5.37-B 5.37 Ab1-42 3.7 ± 1.9 2.8 ± 0.8 3.2 ± 0.2 4.0 ± 0.1 3.3 ± 0.2
5.37-C 5.37 Ab1-39 1.8 ± 0.1 4.0 ± 0.8*** 4.9 ± 0.4*** 4.8 ± 0.6*** 4.2 ± 0.9***
5.37-D 5.37 Ab1-38 9.6 ± 1.9 12.4 ± 1.1 13.1 ± 1.3* 13.4 ± 1.5* 11.9 ± 2.5
5.37-E 5.37 Ab1-37 5.7 ± 1.2 7.2 ± 1.2 8.5 ± 1.6 7.3 ± 1.2 6.8 ± 2.3
5.37-F 5.37 Ab1-41 2.9 ± 1.6 2.7 ± 0.6 3.0 ± 0.3 3.7 ± 0.2 2.5 ± 0.7
6.37-A 6.37 Ab2-40 1.7 ± 0,7 6.0 ± 1.1** 4.2 ± 0.6 2.8 ± 1.1 6.4 ± 3.1***
6.37-B 6.37 Ab2-42 0.6 ± 0.4 4.3 ± 1.2*** 3.7 ± 0.8** 2.5 ± 1.2* 3.5 ± 1.5**
6.37-F 6.37 n. i.,
Ab2-40
a
8.4 ± 5.3 20.1 ± 5.9** 11.4 ± 1.7 4.4 ± 1.5 10.0 ± 2.3
6.37-G 6.37 n. i. 0.5 ± 0.4 4.7 ± 1.2*** 3.8 ± 0.9*** 2.6 ± 1.2* 3.4 ± 1.6**
5.45-A 5.45 n.i.,
Ab2-40
b
1.3 ± 0.9 5.9 ± 1.3** 6.7 ± 0.7*** 5.3 ± 2.0** 6.0 ± 2.9**
Values are expressed as mean ± SD; *P <. 0 5 ,* * P < .01, ***P < .001 compared with CON (one-way ANOVA followed by Dunnett’s multiple comparison test)
n. i. - not identified.
Figure 3 Stimulation with acLDL, polystyrene beads, and LPS induces shifts in proportions of Ab40 variants. The graph depicts the sum
of proportions of the 4 different Ab40 variants after stimulation with LPS, acLDL and polystyrene beads. Note that this sum decreases upon
stimulation but remains almost unaffected by the different stimuli accounting for about 60% of Abtotal. Nonetheless, strong shifts are visible
within single Abx-40 variants resulting in a stimulus-specific signature. Especially the proportion of the Ab peptide migrating at spot 6.37-F -
presumably a variant of Ab2-40 (Ab2-40
a) - shows strong stimulus-dependent shifts.
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secretion by human mononuclear phagocytes. In agree-
ment with our present findings in primary human mono-
nuclear phagocytes, increased levels of APP upon
activation or differentiation were also observed in earlier
studies in microglia and monocytes, respectively [13,31].
Similarly, an increase in the secretion of monomeric Ab
peptides has been observed in immortalized BV-2 mouse
microglial cells upon stimulation with LPS [32]. In con-
trast to mononuclear phagocytes stimulated by phagocyto-
sis, the Ab release signature induced by activation of the
LPS receptor is characterized by only minute proportions
of N-truncated Ab species and a high abundance of Ab1-x,
i.e. Ab species starting with aspartate-1. The signalling
induced by LPS/CD14/TLR4 occurs mainly via the NF-B
pathway. It has been shown that members of the NF-B
family of transcriptional control proteins are critical regu-
lators of APP gene expression and that NF-B inhibitors
decrease both Ab1-40 and Ab1-42 production [33,34].
Unexpectedly, the stimulation of mononuclear phago-
cytes with both polystyrene beads and ac-LDL increased
the protein levels of APP and the release of Ab peptides
as well but elicited a different Ab pattern with increased
proportions of N-truncated Ab species (Ab2-x). The
expression of APP is associated with high membrane
fusion activity [35]. Membrane rearrangement following
phagocytosis includes delivery of new membrane to the
sites of particle ingestion by the unwrinkling of surface
folds and the delivery of endomembranes by focal exo-
cytosis [36-38]. Membrane sources in mammalian pha-
gocytes are recycling endosomes and late endosomes
but also the release of lysosomes has been reported
Figure 4 Shifts in full length APP patterns induced by the glycosylation inhibitors tunicamycin and brefeldin A in mononuclear
phagocyte cultures. Human mononuclear phagocytes were isolated as indicated and left unstimulated on ultra-low attachment plates for
3 days. 6 h, 4 h, 2 h or 0.5 h prior to the lysis of the cells, tunicamycin or brefeldin A were added in a concentration of 10 μg/ml each. Cells
were lysed in RIPA buffer and APP expression was analysed by separation on 7.5% SDS-PAGE, subsequent blotting on PVDF-membranes and
staining with the 1E8 monoclonal antibody. Staining of b-actin served as a loading control. The right hand side shows a molecular weight
standard. Note the slight shift in molecular weight after brefeldin A treatment and the decrease of band APP1 corresponding to mature APP and
the increased amounts of the bands APP2 and APP3 after treatment with Tunicamycin.
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Page 7 of 11Figure 5 Shifts in full length APP patterns induced by acLDL, polystyrene beads, and LPS. Human mononuclear phagocytes were isolated
and cultivated as indicated and left unstimulated (CON) or stimulated with 4*10
7/ml polystyrene beads (PB), 10 μg/ml acLDL (acLDL), 10 ng/ml
LPS (LPS) or a combination of polystyrene beads and LPS (PB+LPS). (A) shows a representative SDS-PAGE/immunoblot of whole cell lysates from
human mononuclear phagocytes after 72 h in vitro immunoreacted with the 1E8 antibody. Staining of the same western blots with a polyclonal
antibody specific for b-actin served as a loading control. (B) Semiquantitative assessment of the changes in expression of total APP (APP1+ APP2
+APP3+APP4) compared to control. (C) Shifts in the ratio APP1:APP2+3 after application of the different stimulation paradigms. Values are
expressed as mean ± SD. *P < .05, **P < .01, ***P < .001 compared with CON (one-way ANOVA followed by Dunnett’s multiple comparison test).
Note the increase in total APP expression under all conditions as well as the increased proportion of APP1 (mature APP) after stimulation with
polysterene beads or acLDL.
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Page 8 of 11[38,39]. Furthermore, APP is involved in monocyte
adhesion to the extracellular matrix or to other cells
[40]. Increased APP expression during phagocytosis
might therefore be important for the function of innate
immunity.
APP deficient in core N-glycosylation is processed
intracellularly, whereas only the mature form is inserted
into the cellular membrane resulting in the secretion of
soluble APP fragments [15-17]. After phagocytic stimuli
elevated proportions of released N-truncated Ab peptides
are accompanied by increased levels of mature APP. This
m i g h ti n d i c a t eas i t eo fA b generation that differs from
that affected by stimulation with LPS. A possible explana-
tion for this observation is the finding that processing of
APP at the plasma membrane seems to promote the
generation of N-terminally truncated Ab peptides [41].
High percentages of N-truncated or posttranslationally
modified Ab peptide species such as 3-pyroglutamate
AbN3-pE and Ab2-x variants have been found in neuritic
and vascular b-amyloid plaques [8,9]. Compared to mouse
models of AD a much higher degree of N-terminal degra-
dation of Ab peptides was found in human samples [42].
Their (sub)cellular origin and their role in amyloidogenesis
in vivo is still only partly understood but it was shown that
aggregation of Ab peptides in vitro is enhanced by N-
terminal deletions [43]. It was further reported that Ab40
oligomerization, in contrast to Ab42 oligomerization, was
particularly sensitive to truncations of the N terminus [44].
Figure 6 Expression of mature APP correlates with the release of N-terminally truncated Ab peptides. For the correlation analysis 12
cultures (1× CON, 4× PB, 2× acLDL, 3× LPS, 2× PB+LPS) were analysed simultaneously for intracellular APP and released Ab-peptides by APP-SDS-
PAGE and 2D-Ab-WIB, respectively. Pearson’s correlation coefficient (r) and the respective p-value were calculated for the association of the relative
amounts of APP band 1 (APP1), band 2 (APP2), band 3 (APP3), and band 4 (APP4) with the relative amounts of N-terminally truncated Ab peptides
migrating at the isoelectric point pI 6.37 (N-truncated Ab). The relative amount of single APP-bands was determined by dividing the signal intensity
of the respective band by the sum of the signal intensities of all four visible APP bands. For the relative amount of N-truncated Ab the sum of all
visible Ab isoforms migrating at pI 6.37 (Ab2-40,A b2-42,A b2-40
a and the Ab peptide at spot 6.37-G) were divided by the sum of all quantified Ab-
peptide spots. The proportion of N-terminally truncated Ab peptides correlates positively with mature APP (APP1) and negatively with APP2.
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Page 9 of 11Upon stimulation the relative proportion of the most
abundant form of Ab,A b1-40, decreased relative to total
Ab by up to 50%. These shifts within the Ab release sig-
nature were particularly visible when only 4 Ab variants
ending at valine-40 (Abx-40) were taken into considera-
tion [24]. 2D-Ab-WIB and semiquantitative assessment
of the proportions of specific Ab variants revealed
pronounced and stimulus-specific shifts towards N-
truncated or otherwise modified variants of Ab2-40 at
the expense of Ab1-40.T h es u mo fa l lt h e s eA b40 var-
iants remained surprisingly stable. In contrast to Abx-40,
the proportions of Abx-42 remained almost unaffected
by the different stimuli. In many cell types, the produc-
tion of Ab peptides occurs predominantly in the endo-
somal/lysosomal compartment and different pools of Ab
peptides with different distributions of single Ab species,
i.e. Ab1-40 and Ab1-42, have been reported [11,45].
Therefore, the shifts in Ab40 variants might reflect a
release from different intracellular pools of Ab peptides.
Conclusions
The present data show that activation of the LPS receptor
and of scavenger receptor-associated signalling pathways
by acLDL and polystyrene beads increases the cellular
protein levels of APP and the secretion of Ab peptides by
human mononuclear phagocytes. The expression of sca-
venger receptors and CD14 - which both bind fibrillar
Ab- is increased in AD. Therefore, it might be speculated
that the presence of fibrillar Ab itself increases the
release of monomeric Ab variants by human phagocytes
and thereby initiates a vicious cycle. Further work is
necessary to assess how stimulus-specific shifts in the Ab
release signature contribute to amyloidogenesis in vivo.
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